{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:25:41Z","timestamp":1782368741819,"version":"3.54.5"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study compared the effectiveness of injectable collagenase clostridium histolyticum and percutaneous needle fasciotomy in the treatment of Dupuytren\u2019s contracture.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with a total passive extension deficit of 30 degrees or more in a single digital ray were enrolled and assigned randomly to receive either collagenase clostridium histolyticum injections or percutaneous needle fasciotomy. Preoperative severity of proximal interphalangeal joint contracture for Dupuytren\u2019s disease was classified according to the British Society for Surgery of the Hand as less than 30 degrees (stage I) or 30 degrees or more (stage II).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of the 70 patients enrolled, 36 patients with 46 joints received collagenase clostridium histolyticum injections and 34 patients with 48 joints received percutaneous needle fasciotomy. At day 30, successful corrections were obtained in only 50 percent of the injection group and 67 percent of the fasciotomy group for stage II proximal interphalangeal joints. Recurrences were frequent among patients with stage II joint contractures. The mean Quick Disabilities of the Arm, Shoulder and Hand questionnaire score at day 30 was significantly higher in the injection group compared with the fasciotomy group (7.5 versus 4.2, respectively). In the injection group, adverse events were reported for all patients. In the fasciotomy group, complications were reported for 15 percent of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The collagenase clostridium histolyticum and percutaneous needle fasciotomy groups had similar outcomes for Dupuytren\u2019s contracture with 3 years\u2019 follow-up. Recurrences were frequent among patients with stage II proximal interphalangeal joint contractures. The Unit\u00e9 Rhumatologique des Affections de la Main scale and Quick Disabilities of the Arm, Shoulder and Hand questionnaire score decreased significantly for both groups at final follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n            <jats:p>Therapeutic, II.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/prs.0000000000006828","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T14:03:44Z","timestamp":1591279424000},"page":"1464-1474","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren\u2019s Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up"],"prefix":"10.1097","volume":"145","author":[{"given":"Yoshihiro","family":"Abe","sequence":"first","affiliation":[{"name":"From the Department of Orthopedic Surgery, Chiba Rosai Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231017","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/1753193410376286","article-title":"The outcome of surgical treatments for primary Dupuytren\u2019s disease: A systematic review.","volume":"35","author":"Becker","year":"2010","journal-title":"J Hand Surg Eur Vol"},{"key":"R2-20231017","first-page":"e15","article-title":"Surgical complications associated with fasciectomy for Dupuytren\u2019s disease: A 20-year review of the English literature.","volume":"10","author":"Denkler","year":"2010","journal-title":"Eplasty"},{"key":"R3-20231017","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhsa.2006.02.021","article-title":"A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren\u2019s disease: A 6-week follow-up study.","volume":"31","author":"van Rijssen","year":"2006","journal-title":"J Hand Surg Am"},{"key":"R4-20231017","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture.","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20231017","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jhsa.2012.06.032","article-title":"Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: The importance of clear definitions.","volume":"37","author":"Werker","year":"2012","journal-title":"J Hand Surg Am"},{"key":"R6-20231017","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11552-011-9326-8","article-title":"A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren\u2019s contracture.","volume":"6","author":"Chen","year":"2011","journal-title":"Hand (N Y)"},{"key":"R7-20231017","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1753193415617385","article-title":"One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren contracture: A two centre prospective randomized clinical trial.","volume":"41","author":"Scherman","year":"2016","journal-title":"J Hand Surg Eur"},{"key":"R8-20231017","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/1753193418786947","article-title":"Three-year recurrence of Dupuytren\u2019s contracture after needle fasciotomy and collagenase injection: A two-centre randomized controlled trial.","volume":"43","author":"Scherman","year":"2018","journal-title":"J Hand Surg Eur Vol"},{"key":"R9-20231017","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhsa.2016.06.014","article-title":"Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: A randomized, single-blinded, clinical trial with a 1-year follow-up.","volume":"41","author":"Str\u00f6mberg","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R10-20231017","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2106\/JBJS.17.01128","article-title":"Percutaneous needle fasciotomy versus collagenase treatment for Dupuytren contracture: A randomized controlled trial with a two-year follow-up.","volume":"100","author":"Str\u00f6mberg","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R12-20231017","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/acr.20564","article-title":"Unite Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren\u2019s disease-specific disability.","volume":"63","author":"Beaudreuil","year":"2011","journal-title":"Arthritis Care Res"},{"key":"R13-20231017","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jhsa.2007.04.002","article-title":"Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren\u2019s contracture.","volume":"32","author":"Badalamente","year":"2007","journal-title":"J Hand Surg Am"},{"key":"R14-20231017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhsa.2012.09.028","article-title":"Dupuytren\u2019s contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.","volume":"38","author":"Peimer","year":"2013","journal-title":"J Hand Surg Am"},{"key":"R16-20231017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753193414528843","article-title":"Safety and tolerability of collagenase clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture.","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Eur Vol"},{"key":"R17-20231017","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2474-13-61","article-title":"Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren\u2019s cords: An exploratory study.","volume":"13","author":"Coleman","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"R18-20231017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhsa.2013.10.002","article-title":"Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures.","volume":"39","author":"Coleman","year":"2014","journal-title":"J Hand Surg Am"},{"key":"R19-20231017","doi-asserted-by":"crossref","first-page":"782e","DOI":"10.1097\/PRS.0000000000005443","article-title":"Collagenase clostridium histolyticum for Dupuytren\u2019s contracture: Comparing single and concurrent injections.","volume":"143","author":"Cook","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R20-20231017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jht.2010.08.006","article-title":"The QuickDASH score: A patient-reported outcome measure for Dupuytren\u2019s surgery.","volume":"24","author":"Budd","year":"2011","journal-title":"J Hand Ther"},{"key":"R21-20231017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/1471-2474-14-131","article-title":"Optimal functional outcome measures for assessing treatment for Dupuytren\u2019s disease: A systematic review and recommendations for future practice.","volume":"14","author":"Ball","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"R22-20231017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jbspin.2014.01.007","article-title":"URAM scale for functional assessment in Dupuytren\u2019s disease: A comparative study of its properties.","volume":"81","author":"Bernab\u00e9","year":"2014","journal-title":"Joint Bone Spine"},{"key":"R23-20231017","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/1753193414524689","article-title":"What patients want from the treatment of Dupuytren\u2019s disease: Is the Unit\u00e9 Rhumatologique des Affections de la Main (URAM) scale relevant?","volume":"40","author":"Rodrigues","year":"2015","journal-title":"J Hand Surg Eur"},{"key":"R24-20231017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1753193416677712","article-title":"Recovery, responsiveness and interpretability of patient-reported outcome measures after surgery for Dupuytren\u2019s disease.","volume":"42","author":"Rodrigues","year":"2017","journal-title":"J Hand Surg Eur Vol"},{"key":"R25-20231017","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1753193417752891","article-title":"Measurement properties of the Dutch Unit\u00e9 Rhumatologique des Affections de la Main and its ability to measure change due to Dupuytren\u2019s disease progression compared with the Michigan Hand Outcomes Questionnaire.","volume":"43","author":"Broekstra","year":"2018","journal-title":"J Hand Surg Eur Vol"},{"key":"R26-20231017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/PRS.0000000000001878","article-title":"Patients\u2019 preferences for treatment for Dupuytren\u2019s disease: A discrete choice experiment.","volume":"137","author":"Kan","year":"2016","journal-title":"Plast Reconstr Surg"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000006828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T22:08:48Z","timestamp":1697580528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000006828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000006828","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}